[1] L. Montalva, L. Antounians, A. Zani, Pulmonary hypertension secondary to congenital diaphragmatic hernia: factors and pathways involved in pulmonary vascular remodeling, Pediatr. Res. 85 (6) (2019) 754–768.
[2] J. Deprest, P. Brady, K. Nicolaides, A. Benachi, C. Berg, J. Vermeesch, G. Gardener, E. Gratacos, Prenatal management of the fetus with isolated congenital diaphragmatic hernia in the era of the TOTAL trial, Semin. Fetal Neonatal Med. 19 (6) (2014) 338–348.
[3] P. Kosinski, K. Luterek, M. Lipa, M. Wielgos, The use of atosiban prolongs pregnancy in patients treated with fetoscopic endotracheal occlusion (FETO), J. Perinat. Med. 47 (9) (2019) 910–914.
[4] R. Cruz-Martínez, M. Martínez-Rodríguez, A. G´amez-Varela, B. Nieto-Castro, J. Luna-García, I. Ju´arez-Martínez, H. Lo´pez-Briones, R. Guadarrama-Mora, J. Torres-Torres, F. Coronel-Cruz, D. Ibarra-Rios, R. Ordorica-Flores, J. Nieto- Zermen˜o, Survival outcomes in severe left diaphragmatic hernia with and without fetoscopic tracheal occlusion in a country with suboptimal neonatal management, Ultrasound in obstetrics & gynecology, in: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2020, https://doi.org/ 10.1002/uog.21993.
[5] L. Lockau, S.A. Atkinson, Vitamin D’s role in health and disease: how does the present inform our understanding of the past? Int. J. Paleopathol. 23 (2018) 6–14.
[6] A.N. Ataman˜uk, D.F. Litewka, S.J. Baratta, I.M. Seropian, G. Perez Prados, M. O. Payaslian, J.P. Ortiz Fragola, P. Escribano Subias, Vitamin D deficiency among patients with pulmonary hypertension, BMC Pulm. Med. 19 (1) (2019), 258-258.
[7] P.N. Black, R. Scragg, Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey, Chest 128 (6) (2005) 3792–3798.
[8] E. Mandell, G. Seedorf, J. Gien, S.H. Abman, Vitamin D treatment improves survival and infant lung structure after intra-amniotic endotoxin exposure in rats: potential role for the prevention of bronchopulmonary dysplasia, Am. J. Physiol. Lung Cell Mol. Physiol. 306 (5) (2014) L420–L428.
[9] H. Tanaka, M. Kataoka, S. Isobe, T. Yamamoto, K. Shirakawa, J. Endo, T. Satoh, Y. Hakamata, E. Kobayashi, M. Sano, K. Fukuda, Therapeutic impact of dietary vitamin D supplementation for preventing right ventricular remodeling and improving survival in pulmonary hypertension, PloS One 12 (7) (2017), e0180615.
[10] H. Yu, M. Xu, Y. Dong, J. Liu, Y. Li, W. Mao, J. Wang, L. Wang, 1,25(OH)2D3 attenuates pulmonary arterial hypertension via microRNA-204 mediated Tgfbr2/ Smad signaling, Exp. Cell Res. 362 (2) (2018) 311–323.
[11] E. Mandell, K.N. Powers, J.W. Harral, G.J. Seedorf, K.S. Hunter, S.H. Abman, R. B. Dodson, Intrauterine endotoxin-induced impairs pulmonary vascular function and right ventricular performance in infant rats and improvement with early vitamin D therapy, Am. J. Physiol. Lung Cell Mol. Physiol. 309 (12) (2015) L1438–L1446.
[12] A. Dovnik, F. Mujezinovi´c, The association of vitamin D levels with common pregnancy complications, Nutrients 10 (7) (2018) 867.
[13] C. Palacios, L.K. Kostiuk, J.P. Pen˜a-Rosas, Vitamin D supplementation for women during pregnancy, Cochrane Database Syst. Rev. 7 (7) (2019). CD008873- CD008873.
[14] C. Palacios, M.A. Trak-Fellermeier, R.X. Martinez, L. Lopez-Perez, P. Lips, J. A. Salisi, J.C. John, J.P. Pen˜a-Rosas, Regimens of vitamin D supplementation for women during pregnancy, Cochrane Database Syst. Rev. 10 (10) (2019). CD013446-CD013446.
[15] G.G. Turkmen, H. Timur, A. Tokmak, Z. Yilmaz, A. Kirbas, K. Daglar, C.Y. Sanhal, D. Uygur, Levels of serum vitamin D and calcium in pregnancies complicated with fetal congenital diaphragmatic hernia and normal pregnancies, J. Matern. Fetal Neonatal Med. 30 (8) (2017) 990–994.
[16] S. Hirako, H. Tsuda, T. Kotani, S. Sumigama, Y. Mano, T. Nakano, K. Imai, H. Li, S. Toyokuni, F. Kikkawa, Antenatal Saireito (TJ-114) can improve pulmonary hypoplasia and pulmonary vascular remodeling in nitrofen-induced congenital diaphragmatic hernia, Phytother Res. 30 (9) (2016) 1474–1480.
[17] Y. Watanabe, H. Tsuda, T. Kotani, S. Sumigama, Y. Mano, M. Hayakawa, Y. Sato, F. Kikkawa, Amniotic lamellar body count and congenital diaphragmatic hernia in humans and in a rat model, Pediatr. Res. 73 (3) (2013) 344–348.
[18] C. Nogueira-Silva, E. Carvalho-Dias, P. Piairo, S. Nunes, M.J. Baptista, R.S. Moura, J. Correia-Pinto, Local fetal lung renin-angiotensin system as a target to treat congenital diaphragmatic hernia, Mol. Med. 18 (2012) 231–243.
[19] G. Crowley, S. Kwon, E.J. Caraher, S.H. Haider, R. Lam, P. Batra, D. Melles, M. Liu, A. Nolan, Quantitative lung morphology: semi-automated measurement of mean linear intercept, BMC Pulm. Med. 19 (1) (2019) 206.
[20] Y. Zhou, B. Zhou, L. Pache, M. Chang, A.H. Khodabakhshi, O. Tanaseichuk, C. Benner, S.K. Chanda, Metascape provides a biologist-oriented resource for the analysis of systems-level datasets, Nat. Commun. 10 (1) (2019) 1523.
[21] H. Tsuda, T. Kotani, T. Nakano, K. Imai, S. Hirako, H. Li, F. Kikkawa, Lipocalin 2 as a new biomarker for fetal lung hypoplasia in congenital diaphragmatic hernia, Clin. Chim. Acta 462 (2016) 71–76.
[22] M. Speeckaert, G.M. Huang, J.R. Delanghe, Y.E.C. Taes, Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism, Clin. Chim. Acta 372 (1–2) (2006) 33–42.
[23] W.Q. Diao, N. Shen, Y.P. Du, B.B. Liu, X.Y. Sun, M. Xu, B. He, Fetuin-B (FETUB): a plasma biomarker candidate related to the severity of lung function in COPD, Sci. Rep. 6 (2016) 30045.
[24] K. Nakamura, M. Sakaguchi, H. Matsubara, S. Akagi, T. Sarashina, K. Ejiri, K. Akazawa, M. Kondo, K. Nakagawa, M. Yoshida, T. Miyoshi, T. Ogo, T. Oto, S. Toyooka, Y. Higashimoto, K. Fukami, H. Ito, Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension, PloS One 13 (9) (2018), e0203046.
[25] G.E. Walker, A. Follenzi, V. Bruscaggin, M. Manfredi, S. Bellone, E. Marengo, L. Maiuri, F. Prodam, G. Bona, Fetuin B links vitamin D deficiency and pediatric obesity: direct negative regulation by vitamin D, J. Steroid Biochem. Mol. Biol. 182 (2018) 37–49.
[26] M.R. Haussler, C.A. Haussler, G.K. Whitfield, J.C. Hsieh, P.D. Thompson, T. K. Barthel, L. Bartik, J.B. Egan, Y. Wu, J.L. Kubicek, C.L. Lowmiller, E.W. Moffet, R. E. Forster, P.W. Jurutka, The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging, J. Steroid Biochem. Mol. Biol. 121 (1–2) (2010) 88–97.
[27] L. Marin, M.E. Dufour, C. Tordet, M. Nguyen, 1,25(OH)2D3 stimulates phospholipid biosynthesis and surfactant release in fetal rat lung explants, Biol. Neonate 57 (3–4) (1990) 257–260.
[28] S. Lykkedegn, G.L. Sorensen, S.S. Beck-Nielsen, H.T. Christesen, The impact of vitamin D on fetal and neonatal lung maturation. A systematic review, Am. J. Physiol. Lung Cell Mol. Physiol. 308 (7) (2015) L587–L602.
[29] M. Al-Beltagi, M. Rowiesha, A. Elmashad, S.M. Elrifaey, H. Elhorany, H.G. Koura, Vitamin D status in preterm neonates and the effects of its supplementation on respiratory distress syndrome, Pediatr. Pulmonol. 55 (1) (2020) 108–115.
[30] O. Boucherat, A. Benachi, B. Chailley-Heu, M.-L. Franco-Montoya, C. Elie, J. Martinovic, J.R. Bourbon, Surfactant maturation is not delayed in human fetuses with diaphragmatic hernia, PLoS Med. 4 (7) (2007) e237-e237.
[31] P.E. Cogo, M. Simonato, O. Danhaive, G. Verlato, G. Cobellis, F. Savignoni, D. Peca, A. Baritussio, V.P. Carnielli, Impaired surfactant protein B synthesis in infants with congenital diaphragmatic hernia, Eur. Respir. J. 41 (3) (2013) 677–682.
[32] Y. Taira, T. Yamataka, E. Miyazaki, P. Puri, Comparison of the pulmonary vasculature in newborns and stillborns with congenital diaphragmatic hernia, Pediatr. Surg. Int. 14 (1–2) (1998) 30–35.
[33] R. Tenbrinck, J.L. Gaillard, D. Tibboel, D. Kluth, B. Lachmann, J.C. Molenaar, Pulmonary vascular abnormalities in experimentally induced congenital diaphragmatic hernia in rats, J. Pediatr. Surg. 27 (7) (1992) 862–865.
[34] C. Luong, J. Rey-Perra, A. Vadivel, G. Gilmour, Y. Sauve, D. Koonen, D. Walker, K. G. Todd, P. Gressens, Z. Kassiri, K. Nadeem, B. Morgan, F. Eaton, J.R. Dyck, S. L. Archer, B. Th´ebaud, Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia, Circulation 123 (19) (2011) 2120–2131.
[35] J. Kattan, C. C´espedes, A. Gonz´alez, C.P. Vio, Sildenafil stimulates and dexamethasone inhibits pulmonary vascular development in congenital diaphragmatic hernia rat lungs, Neonatology 106 (1) (2014) 74–80.
[36] M. Makanga, H. Maruyama, C. Dewachter, A.M. Da Costa, E. Hupkens, G. de Medina, R. Naeije, L. Dewachter, Prevention of pulmonary hypoplasia and pulmonary vascular remodeling by antenatal simvastatin treatment in nitrofen- induced congenital diaphragmatic hernia, Am. J. Physiol. Lung Cell Mol. Physiol. 308 (7) (2015) L672–L682.
[37] B. Qin, H. Yang, B. Xiao, Role of microRNAs in endothelial inflammation and senescence, Mol. Biol. Rep. 39 (4) (2012) 4509–4518.
[38] P. Pereira-Terra, J.A. Deprest, R. Kholdebarin, N. Khoshgoo, P. DeKoninck, A. A. Munck, J. Wang, F. Zhu, R.J. Rottier, B.M. Iwasiow, J. Correia-Pinto, D. Tibboel, M. Post, R. Keijzer, Unique tracheal fluid MicroRNA signature predicts response to FETO in patients with congenital diaphragmatic hernia, Ann. Surg. 262 (6) (2015) 1130–1140.
[39] A. Tachi, Y. Moriyama, H. Tsuda, R. Miki, T. Ushida, M. Miura, Y. Ito, K. Imai, T. Nakano-Kobayashi, M. Hayakawa, F. Kikkawa, T. Kotani, A proteome signature of umbilical cord serum associated with congenital diaphragmatic hernia, Nagoya J. Med. Sci. 82 (2) (2020) 345–354.
[40] J.L. Peiro, M. Oria, E. Aydin, R. Joshi, N. Cabanas, R. Schmidt, C. Schroeder, M. Marotta, B.M. Varisco, Proteomic profiling of tracheal fluid in an ovine model of congenital diaphragmatic hernia and fetal tracheal occlusion, Am. J. Physiol. Lung Cell Mol. Physiol. 315 (6) (2018) L1028–l1041.
[41] E. Cotroneo, A. Ashek, L. Wang, J. Wharton, O. Dubois, S. Bozorgi, M. Busbridge, K. N. Alavian, M.R. Wilkins, L. Zhao, Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat, Circ. Res. 116 (10) (2015) 1680–1690.
[42] L. Ramakrishnan, S.L. Pedersen, Q.K. Toe, L.E. West, S. Mumby, H. Casbolt, T. Issitt, B. Garfield, A. Lawrie, S.J. Wort, G.J. Quinlan, The Hepcidin/Ferroportin axis modulates proliferation of pulmonary artery smooth muscle cells, Sci. Rep. 8 (1) (2018) 12972.
[43] C.M. Wong, I.R. Preston, N.S. Hill, Y.J. Suzuki, Iron chelation inhibits the development of pulmonary vascular remodeling, Free Radic. Biol. Med. 53 (9) (2012) 1738–1747.
[44] S. Toyokuni, Role of iron in carcinogenesis: cancer as a ferrotoxic disease, Canc. Sci. 100 (1) (2009) 9–16.
[45] C. Carvalho, T. Isakova, G. Collerone, G. Olbina, M. Wolf, M. Westerman, O. M. Guti´errez, Hepcidin and disordered mineral metabolism in chronic kidney disease, Clin. Nephrol. 76 (2) (2011) 90–98.
[46] J. Bacchetta, J.J. Zaritsky, J.L. Sea, R.F. Chun, T.S. Lisse, K. Zavala, A. Nayak, K. Wesseling-Perry, M. Westerman, B.W. Hollis, I.B. Salusky, M. Hewison, Suppression of iron-regulatory hepcidin by vitamin D, J. Am. Soc. Nephrol. 25 (3) (2014) 564–572.
[47] H. Moran-Lev, T. Galai, A. Yerushalmy-Feler, Y. Weisman, A. Anafy, V. Deutsch, M. Cipok, R. Lubetzky, S. Cohen, Vitamin D decreases hepcidin and inflammatory markers in newly diagnosed inflammatory bowel disease paediatric patients: a prospective study, J Crohns Colitis 13 (10) (2019) 1287–1291.
[48] S. Hirako, H. Tsuda, F. Ito, Y. Okazaki, T. Hirayama, H. Nagasawa, T. Nakano, K. Imai, T. Kotani, F. Kikkawa, S. Toyokuni, Role of catalytic iron and oxidative stress in nitrofen-induced congenital diaphragmatic hernia and its amelioration by Saireito (TJ-114), J. Clin. Biochem. Nutr. 61 (3) (2017) 176–182.
[49] K.M. Groom, W. Ganzevoort, Z. Alfirevic, K. Lim, A.T. Papageorghiou, S. Consortium, Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): comment from the STRIDER Consortium, Ultrasound in obstetrics & gynecology, Off. J. Int. Soc. Ultrasound Obstet. Gynecol. 52 (3) (2018) 295–296.
[50] J. Verhaeghe, M. Thomasset, A. Br´ehier, F.A. Van Assche, R. Bouillon, 1,25(OH)2D3 and Ca-binding protein in fetal rats: relationship to the maternal vitamin D status, Am. J. Physiol. 254 (4 Pt 1) (1988) E505–E512.
[51] D.S. Mous, H.M. Kool, P.E. Burgisser, M.J. Buscop-van Kempen, K. Nagata, A. Boerema-de Munck, J. van Rosmalen, O. Dzyubachyk, R.M.H. Wijnen, D. Tibboel, R.J. Rottier, Treatment of rat congenital diaphragmatic hernia with sildenafil and NS-304, selexipag’s active compound, at the pseudoglandular stage improves lung vasculature, Am. J. Physiol. Lung Cell Mol. Physiol. 315 (2) (2018) L276–l285.
[52] L. Lemus-Varela Mde, A. Soliz, B.C. Go´mez-Meda, A.L. Zamora-Perez, J.M. Ornelas-Aguirre, V. Melnikov, B.M. Torres-Mendoza, G.M. Zún˜iga-Gonz´alez, Antenatal use of bosentan and/or sildenafil attenuates pulmonary features in rats with congenital diaphragmatic hernia, World J. Pediatr. 10 (4) (2014) 354–359.